Pharmaceutical Technology Europe, Nov 1, 2009 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Nov 1, 2009
Packaging Special Feature
The pharmaceutical packaging market
By Fedra Pavlou , Stephanie Sutton , Corrine Lawrence
According to a survey conducted by Pharmaceutical Technology Europe (PTE), almost 50% of you believe that cost is the biggest limiting factor to innovation in the pharmaceutical packaging industry.
Packaging: the experts' view
By Friedbert Klefenz , Carsten Peters , Piero Tomasi , Jürgen Schäfer
What trends have you witnessed in the pharmaceutical packaging industry in the last 2 years?
Trends in labelling
By Mark Beauchamp
Following years of development, DataMatrix codes are now a viable labelling solution for pharma manufacturers.
Developing a modified Pulsincap system
By Gayatri C. Patel , Madhabhai M. Patel
Chronotherapeutic drug delivery systems (CRDDS) have been recognized as potentially beneficial to the chronotherapy (timeoptimized therapy) of widespread chronic diseases that display time-dependent symptoms.
Case study
Case study: printing powders with Sticky Web technology
By Howard Biddle
GlaxoSmithKline (GSK) appointed 42 Technology (42T) to evaluate existing powder dispensing approaches that could be scaled for high speed manufacturing.
Ask the Expert
Regulatory challenges of inhaler testing
By Mark Copley
Mark Copley discusses the methods used for DPI testing and the challenges presented by the current regulatory framework.
Outsourcing Review
Reality not insanity
By Jim Miller
Apopular definition of insanity is repeating the same task over and over again while expecting a different result. It would appear, therefore, that many people in the contract services industry think the major global bio/pharma companies are insane.
Demographic time bomb
By Faiz Kermani
Population ageing is an issue often discussed in the media, but its impact on all facets of life has been poorly characterized.
Talking Point
Simplifying data management
By Sebastian Goettel
Paper is no longer a sufficient format for information storage and interchange in the pharmaceutical industry; documents are inflexible and costly for production and storage.
A round-up of news from across the industry.
Editor's Comment
Have your say
By Fedra Pavlou
November is finally upon us and the days are getting colder and shorter.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here